107 related articles for article (PubMed ID: 299750)
21. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
[TBL] [Abstract][Full Text] [Related]
22. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
[TBL] [Abstract][Full Text] [Related]
23. In vivo and in vitro humoral immunity in surgical patients: antibody response to pneumococcal polysaccharide.
Nohr CW; Latter DA; Meakins JL; Christou NV
Surgery; 1986 Aug; 100(2):229-38. PubMed ID: 3488597
[TBL] [Abstract][Full Text] [Related]
24. Is the delayed-type hypersensitivity observed after a low dose of antigen mediated by helper T cells?
Milon G; Marchal G; Seman M; Truffa-Bachi P; Zilberfarb V
J Immunol; 1983 Mar; 130(3):1103-7. PubMed ID: 6218199
[TBL] [Abstract][Full Text] [Related]
25. Thymic hormonal activity on human peripheral blood lymphocytes, in vitro. I. Reciprocal effect on T and B rosette formation.
Shoham J; Cohen M; Chandali Y; Avni A
Immunology; 1980 Oct; 41(2):353-9. PubMed ID: 6969219
[TBL] [Abstract][Full Text] [Related]
26. [Lymphocytes. Roles in cellular immunity and humoral immunity].
Golovtchenko AM; Raichvarg D
Ann Biol Clin (Paris); 1975; 33(2):63-74. PubMed ID: 1080972
[TBL] [Abstract][Full Text] [Related]
27. Regulation of delayed-type hypersensitivity-like responses in the mouse lung, determined with histological procedures: serotonin, T-cell suppressor-inducer factor and high antigen dose tolerance regulate the magnitude of T-cell dependent inflammatory reactions.
Garssen J; Nijkamp FP; Wagenaar SS; Zwart A; Askenase PW; Van Loveren H
Immunology; 1989 Sep; 68(1):51-8. PubMed ID: 2807371
[TBL] [Abstract][Full Text] [Related]
28. Delayed type hypersensitivity: current theories with an historic perspective.
Black CA
Dermatol Online J; 1999 May; 5(1):7. PubMed ID: 10673450
[TBL] [Abstract][Full Text] [Related]
29. [Transfer of delayed type hypersensitivity in guinea pigs].
Smogorzewska E
Probl Med Wieku Rozwoj; 1990; 16():167-88. PubMed ID: 2152405
[TBL] [Abstract][Full Text] [Related]
30. Rosette-forming ability of thymus-derived lymphocytes in cell-mediated immunity. I. Delayed hypersensitivity and in vitro cytotoxicity.
Elliott BE; Haskill JS; Axelrad MA
J Exp Med; 1975 Mar; 141(3):584-99. PubMed ID: 1078841
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous basophil hypersensitivity uncovered in the cell transfer of classical tuberculin hypersensitivity.
Askenase PW
J Immunol; 1976 Sep; 117(3):741-7. PubMed ID: 1085308
[TBL] [Abstract][Full Text] [Related]
32. [Modulating action of interferon preparations on cellular reactions of antitumor immunity].
Mkrtchian LN; Ter-Pogosian ZR; Sarkisian OM; Gevorkian RA; Movsesian EA
Vopr Onkol; 1983; 29(8):7-11. PubMed ID: 6351429
[TBL] [Abstract][Full Text] [Related]
33. [Delayed hypersensitivity to staphylococcal antigens in patients with staphylodermas].
Lesnitskiĭ AI
Vestn Dermatol Venerol; 1990; (1):46-53. PubMed ID: 2327171
[TBL] [Abstract][Full Text] [Related]
34. [Changes in rosette count under the effect of tuberculin antigen (in vitro study of tuberculin type hypersensitivity)].
Katona Z; Nádasdy T
Orv Hetil; 1981 Apr; 122(16):943-5. PubMed ID: 6973120
[No Abstract] [Full Text] [Related]
35. [Active E rosette test in the study of PPD hypersensitivity].
Cesano L; Tartaglino B; Barbalonga A; Vietti Tamus G
Arch Sci Med (Torino); 1980; 137(4):559-62. PubMed ID: 7247671
[TBL] [Abstract][Full Text] [Related]
36. Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte.
Marchal G; Seman M; Milon G; Truffa-Bachi P; Zilberfarb V
J Immunol; 1982 Sep; 129(3):954-8. PubMed ID: 6980927
[TBL] [Abstract][Full Text] [Related]
37. Anti-T cell monoclonal antibodies in vivo. I. Inhibition of delayed hypersensitivity but not cutaneous basophil hypersensitivity reactions.
Sobel RA; Hanzakos JL; Blanchette BW; Williams AM; Dellapelle P; Colvin RB
J Immunol; 1987 Apr; 138(8):2500-6. PubMed ID: 3494071
[TBL] [Abstract][Full Text] [Related]
38. Suppression of delayed hypersensitivity to tuberculin by antigenic competition. A positive immunoregulatory mechanism sensitive to cyclophosphamide.
Dwyer JM; Parker D; Turk JL
Immunology; 1981 Apr; 42(4):549-59. PubMed ID: 6453829
[TBL] [Abstract][Full Text] [Related]
39. Evanescent delayed-type hypersensitivity: mediation by effector cells with a short life span.
Askenase PW; Hayden B; Gershon RK
J Immunol; 1977 Nov; 119(5):1830-5. PubMed ID: 303252
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the functional activity of human lymphocytes in malignant disease by the local graft-versus-host reaction in rats and the T rosette-forming cell test.
Shohat B; Joshua H
Clin Exp Immunol; 1976 Jun; 24(3):534-7. PubMed ID: 7371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
